Clinical Trial Update: Chloroquine as a Modulator of T Cell Immune Activation [NA]

View source ↗

Summary

The trial evaluated chloroquine as a modulator of T cell immune activation in people with HIV, and the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Chloroquine (chloroquine)

Snippet

Sponsor: CIHR Canadian HIV Trials Network | Conditions: HIV | NA | Status: COMPLETED